https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08838-0
0
0
69 words
0
Comments
Background Whether different anti-hepatitis B virus (HBV) drugs have different effects on COVID-19 is controversial. We aimed to evaluate the incidence of COVID-19 in chronic hepatitis B (CHB) patients receiving anti-HBV treatment, and to compare the impact o…
You are the first to view
Create an account or login to join the discussion